Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial-Reference-Cited by-同舟云学术

Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial

Published:2016-06-21 Issue:15 Volume:76 Page:1399-1408
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kulac Ibrahim¹,Gumuskaya Berrak¹,Drake Charles G.²³⁴,Gonzalez Beverly⁵,Arnold Kathryn B.⁶,Goodman Phyllis J.⁶,Kristal Alan R.⁷,Lucia M. Scott⁸,Thompson Ian M.⁹¹⁰,Isaacs William B.³⁴,De Marzo Angelo M.¹³⁴,Platz Elizabeth A.³⁴⁵

Affiliation:

1. Department of Pathology; Johns Hopkins University School of Medicine; Baltimore Maryland

2. Department of Immunology; Johns Hopkins University School of Medicine; Baltimore Maryland

3. Department of Urology; James Buchanan Brady Urological Institute; Johns Hopkins University School of Medicine; Baltimore Maryland

4. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland

5. Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland

6. SWOG Statistical Center; Fred Hutchinson Cancer Research Center; Seattle Washington

7. Cancer Prevention Program; Public Health Sciences Division; Fred Hutchinson Cancer Research Center; Seattle Washington

8. Department of Pathology; University of Colorado Anschutz Medical Campus; Aurora Colorado

9. Department of Urology; University of Texas Health Science Center at San Antonio; San Antonio Texas

10. Department of Cancer Therapy and Research Center; University of Texas Health Science Center at San Antonio; San Antonio Texas

Funder

National Institute of Diabetes and Digestive, and Kidney Diseases

National Cancer Institute

Publisher

Wiley

Subject

Urology,Oncology

Reference26 articles.

1. The picture of the prostatic lymphokine network is becoming increasingly complex;Steiner;Rev Urol,2002

2. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia;Nickel;BJU Int,1999

3. Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen;Morote;Eur Urol,2000

4. Chronic inflammation in benign prostatic hyperplasia: Implications for therapy;Wang;Med Hypotheses,2008

5. Prostate biopsy markers of inflammation are associated with risk of clinical progression of benign prostatic hyperplasia: Findings from the MTOPS study;Torkko;J Urol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial;Cancer Prevention Research;2020-06-24

2. Urinary Biomarkers and Benign Prostatic Hyperplasia;Current Bladder Dysfunction Reports;2019-04-23

3. The Relationship Between Inflammation and LUTS/BPH;Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia;2018

4. Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients;The Prostate;2017-10-27

5. Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens;Oncology Letters;2017-07-26